and the University of Tokyo has made a significant breakthrough in the fight against cancer by developing a highly selective inhibitor for an enzyme called Matrix Metallopeptidase 7 (MMP7).

A new study has created a highly selective inhibitor for Matrix Metallopeptidase 7 (MMP7), an enzyme important for cancer spread and progression. Using advanced peptide discovery technology ...

and the University of Tokyo has made a significant breakthrough in the fight against cancer by developing a highly selective inhibitor for an enzyme called Matrix Metallopeptidase 7 (MMP7).

1 Department of Blood Transfusion, Changzhou Hospital of Traditional Chinese Medicine, Changzhou, Jiangsu, China 2 Department of Laboratory Medicine, Northern Jiangsu People’s Hospital Affiliated to ...

Hepatoblastoma is the most common malignant liver tumor in childhood. Data from Surveillance Epidemiology and End Results (SEER) estimate an incidence of 0.5–1.5 cases per million children per ...

The current study involved analyzing serum samples from 37 Egyptian children aged 1–8 years, including 10 healthy individuals, 14 having FH-WTs and 13 having UnFH-WTs). No congenital anomalies ...

Radiochemical Studies Laboratory, INRASTES, N.C.S.R. “Demokritos”, Agia Paraskevi Attikis, 15310 Athens, Greece Institute of Pharmaceutical Research & Technology (IFET), 18th km of Marathonos Avenue, ...

Objectives To assess the effectiveness and safety of electroacupuncture (EA) combined with rehabilitation therapy (RT) and/or conventional drugs (CD) for improving poststroke motor dysfunction (PSMD).